Medical device design, manufacture and testing systems

Patent metadata

Field	Value
Publication number	US-9388451-B2
Application number	US-201314038080-A
Country	US
Kind code	B2
Filing date	Sep 26, 2013
Priority date	Sep 26, 2012
Publication date	Jul 12, 2016
Grant date	Jul 12, 2016

Abstract

Described are methods and systems for testing lumens of cannulated delivery components or assemblies thereof that may be used to deliver cells to a patient. Test cells are contacted with walls of the lumens and/or liquids that contact walls of the lumens, potentially over an incubation period. The test cells are then assessed for an effect of the wall contact, or the liquid contact, on at least one and preferably multiple characteristics of the test cells such as innate immune response, metabolic activity, viability, cytotoxic response, and/or motility. Methods and systems as described can be used in the development and/or manufacture of cannulated delivery devices, for example providing specifications for design or process inputs or outputs, design or process validations, and/or device lot approvals. Also described are devices or products produced in accordance with such methods and systems.

First claim

The invention claimed is:

1. A method for testing a material of construction of a lumen of a medical device for a potential effect of the lumen on cells delivered through the lumen, comprising:
injecting a liquid medium into the lumen;
incubating the liquid medium injected into the lumen in contact with a material of construction of a wall of the lumen;
collecting the liquid medium from the lumen after said incubating to provide a collected liquid medium;
contacting at least one cell with the collected liquid medium, wherein the at least one cell includes exogenous DNA encoding at least one toll-like receptor; and
assessing the effect of said contact with a material of construction on the expression of the at least one toll-like receptor by the cell, so as to assess the lumen for a potential effect of the lumen on cells delivered through the lumen.

2. The method of claim 1 , wherein the medical device is a catheter.

3. The method of claim 1 , wherein the at least one cell is a population of cells, and wherein the population of cells is a clonal population.

4. The method of claim 1 , wherein the cell is a mammalian cell.

5. The method of claim 1 , wherein the cell is a human cell.

6. The method of claim 1 , wherein the at least one toll-like receptor includes toll-like receptor 2 , toll-like receptor 4 , or both.

7. A method for testing a material of construction of a lumen of a medical device for a potential effect of the lumen on cells delivered through the lumen, comprising:
first assessing the material of construction of the lumen while the lumen is intact for an effect of the lumen on innate immune response of a cell; and
second assessing the material of construction of the lumen while the lumen is intact for an effect of the lumen on at least one other characteristic of a cell, said at least one other characteristic selected from cytotoxicity, motility, viability, and metabolic activity,
so as to assess the lumen for a potential effect of the lumen on cells delivered through the lumen.

8. The method of claim 7 , wherein the medical device is a catheter.

9. The method of claim 7 , wherein said second assessing includes assessing the effect of the lumen on both cytotoxicity to a cell and metabolic activity of a cell.

10. A method for assessing a material of construction of a lumen of a medical device for a potential effect of the lumen on cells delivered through the lumen, comprising:
contacting at least one cell with a liquid medium that has been incubated within the lumen in contact with a material of construction of a wall of the lumen; and
assessing the effect of said contacting on at least one characteristic of the at least one cell, wherein the at least one characteristic includes an innate immune response of the cell,
so as to assess the lumen for a potential effect of the lumen on cells delivered through the lumen.

11. The method of claim 10 , wherein the medical device is a catheter.

12. The method of claim 10 , wherein said at least one characteristic also includes metabolic activity.

13. A method for testing a lumen formed by components of an assembly for a potential effect of the lumen on cells delivered through the lumen, comprising:
incubating a liquid medium within a lumen in contact with a wall of the lumen of a sample assembly including a sample first component coupled to a sample second component to form the lumen;
collecting the liquid medium after said incubating to provide a collected liquid medium;
contacting at least one cell with the collected liquid medium; and
assessing the effect of said contacting on at least one characteristic of the cell,
so as to assess the lumen for a potential effect of the lumen on cells delivered through the lumen.

14. The method of claim 13 , wherein the first sample component is a catheter and the second sample component is a needle or syringe barrel.

15. The method of claim 13 , wherein the cell is a mammalian cell.

16. The method of claim 13 , wherein the cell is a human cell.

17. A kit manufacturing method including assessment of a passageway for a potential effect of the passageway on cells delivered through the passageway, comprising:
manufacturing a first device lot including a plurality of units of a first delivery component each having a first lumen for passage of cells;
manufacturing a second device lot including a plurality of units of a second delivery component each having a second lumen for passage of cells, wherein the first delivery component is associable with the second delivery component to provide a delivery assembly having a passageway for passing cells, the passageway including the first lumen and second lumen;
sampling the first device lot to obtain first test sample units of the first delivery component;
sampling the second device lot to obtain second test sample units of the second delivery component;
associating one of said first test sample units with one of said second sample units to provide a sample delivery assembly having a passageway including the first lumen of the first test sample unit and the second lumen of the second sample unit;
assessing the passageway for an effect of the passageway on at least one characteristic of a cell so as to assess the passageway for a potential effect of the passageway on cells delivered through the passageway; and
packaging first delivery components from the first device lot with second delivery components from the second device lot.

18. The method of claim 17 , wherein said assessing comprises:
passing cells through the passageway;
recovering the cells after said passing; and
assessing the recovered cells for an effect of the passageway on at least one characteristic of the cells.

19. The method of claim 17 , wherein said assessing comprises:
incubating a liquid medium in contact with a wall of the passageway, said wall including wall portions from the first lumen and wall portions from the second lumen, to form a treated medium; and
contacting cells with the treated medium.

20. The method of claim 17 , also comprising, prior to said packaging, determining that said sample delivery assembly meets at least one predetermined criterion related to said effect on at least one characteristic of a cell.

Assignees

• Cook Biotech Inc
• Muffin Inc

Inventors

• Ramachandran Niraj
• Fischer Jr Frank J
• Hiles Michael C
• Fearnot Neal E

Classifications

• G01N33/566

  using specific carrier or receptor proteins as ligand binding reagents {where possible specific carrier or receptor proteins are classified with their target compounds} · CPC title

• G01N33/5005 Primary

  involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025) · CPC title

• G01N33/5014

  for testing toxicity · CPC title

• C12Q1/42 Primary

  involving phosphatase · CPC title

• G01N33/502

  for testing non-proliferative effects · CPC title